  Testing for infection with SARS-CoV-2 is an important intervention in
reducing onwards transmission of COVID-19, particularly when combined with the
isolation and contact-tracing of positive cases. Many countries with the
capacity to do so have made use of lab-processed Polymerase Chain Reaction
(PCR) testing targeted at individuals with symptoms and the contacts of
confirmed cases. Alternatively, Lateral Flow Tests (LFTs) are able to deliver a
result quickly, without lab-processing and at a relatively low cost. Their
adoption can support regular mass asymptomatic testing, allowing earlier
detection of infection and isolation of infectious individuals. In this paper
we extend and apply the agent-based epidemic modelling framework Covasim to
explore the impact of regular asymptomatic testing on the peak and total number
of infections in an emerging COVID-19 wave. We explore testing with LFTs at
different frequency levels within a population with high levels of immunity and
with background symptomatic PCR testing, case isolation and contact tracing for
testing. The effectiveness of regular asymptomatic testing was compared with
`lockdown' interventions seeking to reduce the number of non-household contacts
across the whole population through measures such as mandating working from
home and restrictions on gatherings. Since regular asymptomatic testing
requires only those with a positive result to reduce contact, while lockdown
measures require the whole population to reduce contact, any policy decision
that seeks to trade off harms from infection against other harms will not
automatically favour one over the other. Our results demonstrate that, where
such a trade off is being made, at moderate rates of early exponential growth
regular asymptomatic testing has the potential to achieve significant infection
control without the wider harms associated with additional lockdown measures.
